Misha Angrist states that companies and consumers need to follow the directions of regulatory authorities before accessing their genomes and personal-genomics service. Regulatory authorities need to understand that such services can provide significant benefits to consumers and the overall society. the New England Journal of Medicine has expressed concerns over the development and introduction of genome-based technologies and services. The journal reveals that extensive tests need to conducted on these products before allowing consumers to access them. Regulatory authorities in the US have warned companies that develop such provide such products and provide personal-genomics service to get permits from the concerned authorities before allowing consumers to access them. The State of California has urged these companies to avoid offering tests to consumers without a physician's order.